Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
From Staten Island to Northern Manhattan, Columbia's Cancer Center works side by side with the communities it serves, putting research into action through programs that address critical needs.
Columbia cancer researchers have discovered how melanoma can hide from our immune system, pointing to ways drug developers might restore the tumor’s vulnerability.
The School of Nursing's Phoenix Matthews shares how they merged once-separate identities as psychologist and activist to fight cancer-related health disparities in underserved populations.
Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.